Clinique
- Address
- 9 Avenue Louis Armand, 95120 Ermont, France
Clinique - Urological Oncology Research Center
This center specializes in innovative research for urological malignancies, with a particular focus on bladder cancer treatment optimization. The facility conducts advanced clinical trials investigating novel therapeutic combinations for patients with high-risk bladder conditions following surgical intervention.
- High-risk non-muscle invasive bladder cancer (NMIBC) treatment strategies
- Immunotherapy combinations with BCG (Bacillus Calmette-Guerin)
- Post-transurethral resection bladder tumor management
The center's research program emphasizes event-free survival outcomes through Phase III clinical trials, evaluating cutting-edge immunotherapeutic agents such as atezolizumab in combination with standard BCG therapy. This work aims to establish new treatment paradigms for BCG-naïve patients with high-risk non-muscle invasive bladder cancer.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Unicancer1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinique
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase III Randomized Trial of Atezolizumab Plus BCG Versus BCG Alone in High-Risk Non-Muscle Invasive Bladder Cancer Patients | Unicancer | Phase III | Not Yet Recruiting | — | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Atezolizumab | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.